Exploring complement activation to develop biomarkers for systemic lupus erythematosus
Open Access
- 4 November 2004
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (11) , 3404-3407
- https://doi.org/10.1002/art.20602
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cell signals transduced by complementMolecular Immunology, 2004
- Biomarkers in systemic lupus erythematosus: I. General overview of biomarkers and their applicabilityArthritis & Rheumatism, 2004
- The alternative pathway of complement in disease: opportunities for therapeutic targetingMolecular Immunology, 2004
- The Intricate Role of Complement Component C4 in Human Systemic Lupus ErythematosusPublished by S. Karger AG ,2003
- Autoimmunity, Complement Activation, Tissue Injury and Reciprocal EffectsPublished by S. Karger AG ,2003
- The Biological Functions of MBL-Associated Serine Proteases (MASPs)Immunobiology, 2002
- Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complementArthritis & Rheumatism, 1992
- Structural differences between the two human complement C4 isotypes affect the humoral immune response.The Journal of Experimental Medicine, 1992
- Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.Journal of Clinical Investigation, 1985
- Mode of Inheritance of Decreased C3b Receptors on Erythrocytes of Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1982